At Illingworth Research Group, our staff have many years’ experience in providing a wide range of clinical development services to the pharmaceutical, biotechnology and medical device industries. We are a contract research organisation (CRO) specialising in Phase I to IV clinical trials and in the provision of mobile clinical research nurses and medical photography. We have a wealth of experience in many therapeutic areas and in particular, respiratory, dermatology and oncology.
Unlike many CROs, we only take on projects that we know we can deliver to a high standard. Illingworth does not have the full-service capability, but what we do, we do well. We work with a biometrics provider who are experts in their field, as we are in ours. Our clients appreciate this honesty and integrity.
In many cases, it can be faster to obtain regulatory approvals for studies in the UK. We had the unique experience of being the first CRO to use the new HRA approval process for a commercial CTIMP, several months before it was due to be launched. During this process we worked with the HRA to help develop the procedures; we worked with the sites involved to help them work their way through this brand new system. We have an extensive network of contacts within the UK industry and can put you in touch with the right people for your business. We can help you understand market access, clinical study requirements and study planning. If you are located outside the UK but have an interest in this market, we will be happy to assist you. We have been successful UK partners for US based Biotechnology organisations and provide EU legal representative services for those companies who are not present in Europe.